Skip to main content
. 2005 Jul 26;106(10):3666–3672. doi: 10.1182/blood-2005-02-0479

Table 4.

Phenotypic analysis of KIR expression on CD56+ cells of HLA-matched donors used as effector cells in Figure 3C-D

% CD56+
Donor HLA-Cw HLA-C group KIR2DL1 KIR2DL2 KIR2DL2/KIR2DL1 ratio
Patient 4 03/07 1/1 7 10 1.4
Patient 5 04/15 2/2 8 4.5 0.6